Advice

following an abbreviated submission:

midazolam (Epistatus®) is accepted for use within NHS Scotland.

Indication under review: treatment of prolonged, acute, convulsive seizures in children and adolescents aged 10 to less than 18 years.

The availability of midazolam (Epistatus) provides a licensed alternative to a previously available unlicensed preparation (10mg/mL).

Download detailed advice135KB (PDF)

Download

Medicine details

Medicine name:
midazolam (Epistatus)
SMC ID:
1279/17
Indication:
Treatment of prolonged, acute, convulsive seizures in children and adolescents aged 10 to less than 18 years.
Pharmaceutical company
Special Products Ltd
BNF chapter
Central nervous system
Submission type
Abbreviated
Status
Accepted
Date advice published:
13 November 2017